Literature DB >> 20585978

Infection with specific Helicobacter pylori-cag pathogenicity island strains is associated with interleukin-1B gene polymorphisms in Venezuelan chronic gastritis patients.

Miguel Angel Chiurillo1, Yeinmy H Moran, Miryan Cañas, Elvis J Valderrama, Emma Armanie.   

Abstract

BACKGROUND: The cag pathogenicity island (cag-PAI) is one of the major virulence factors of Helicobacter pylori, showing considerable geographic variation. AIM: We investigated the prevalence of cagA, cagE, and cagT genes of cag-PAI and their association with proinflammatory IL-1B-511/-31/+3954 polymorphisms in Venezuelan chronic gastritis patients from a high-risk gastric cancer region.
METHODS: Presence of cag-PAI genes and IL-1B polymorphisms in 121 biopsy specimens was evaluated by polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (RFLP), respectively.
RESULTS: cagA (+) and triple-positive (cagAET (+)) strains were detected in 79.3% and 70.2% of patients, respectively. We found that infection with cagA (+) and cagAET (+) strains was associated (P < 0.05) with hosts harboring both IL-1B +3954C allele and IL-1B-511T/-31C/+3954C haplotype (TCC (+)). The frequency of gastric atrophy was significantly higher (P < 0.020) among cagAET (+)/IL-1B-TCC (+) combined genotype carriers.
CONCLUSION: Carriage of IL-1B +3954C allele and IL-1B-TCC (+) haplotype could favor colonization of bacterial cagAET (+) strains, and the combination of these bacterial and host haplotypes could play a synergistic role in development of premalignant gastric lesions. This work contributes to understanding of the complex interaction between H. pylori virulence factors and cytokine genotypes involved in gastrointestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585978     DOI: 10.1007/s10620-010-1316-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica.

Authors:  W Alpízar-Alpízar; G I Pérez-Pérez; C Une; P Cuenca; R Sierra
Journal:  Clin Exp Med       Date:  2005-12       Impact factor: 3.984

2.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

3.  High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects.

Authors:  C Ghose; G I Perez-Perez; L J van Doorn; M G Domínguez-Bello; M J Blaser
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Prevalence of Helicobacter pylori cagA, iceA and babA2 alleles in Brazilian patients with upper gastrointestinal diseases.

Authors:  Luciano Lobo Gatti; José Luiz Proença Módena; Spencer Luiz Marques Payão; Marília de Arruda Cardoso Smith; Yara Fukuhara; José Luiz Pimenta Módena; Ricardo Brandt de Oliveira; Marcelo Brocchi
Journal:  Acta Trop       Date:  2006-12-19       Impact factor: 3.112

Review 5.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

6.  Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa.

Authors:  Roland Rad; Christian Prinz; Bruno Neu; Mathilde Neuhofer; Marco Zeitner; Petra Voland; Ingrid Becker; Wolfgang Schepp; Markus Gerhard
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

7.  [Interleukin-1 genetic polymorphism: association with gastric cancer in the high-risk Central-Western population of Venezuela].

Authors:  Miryan Cañas; Yeinmy Morán; María Belén Rivero; Adolfo Bohórquez; Venus Villegas; Yanet Rendón; Eddy Ramírez; Elvis Valderrama; Zuly Briceño; Miguel Angel Chiurillo
Journal:  Rev Med Chil       Date:  2009-04-23       Impact factor: 0.553

8.  Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates.

Authors:  Lino E Torres; Karelia Melián; Arlenis Moreno; Jordis Alonso; Carlos A Sabatier; Mayrín Hernández; Ludisleydis Bermúdez; Boris L Rodríguez
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

Review 9.  Role of type IV secretion in Helicobacter pylori pathogenesis.

Authors:  Steffen Backert; Matthias Selbach
Journal:  Cell Microbiol       Date:  2008-04-08       Impact factor: 3.715

Review 10.  Helicobacter pylori persistence: biology and disease.

Authors:  Martin J Blaser; John C Atherton
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more
  5 in total

Review 1.  Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries.

Authors:  Miguel Angel Chiurillo
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

2.  Helicobacter pylori Infection in Rural and Urban Dyspeptic Patients from Venezuela.

Authors:  Monica Contreras; Milagro Fernández-Delgado; Nelson Reyes; María Alexandra García-Amado; Héctor Rojas; Fabian Michelangeli
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

Review 3.  Factors that mediate colonization of the human stomach by Helicobacter pylori.

Authors:  Ciara Dunne; Brendan Dolan; Marguerite Clyne
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Genetic variation in PSCA and risk of gastric advanced preneoplastic lesions and cancer in relation to Helicobacter pylori infection.

Authors:  Cosmeri Rizzato; Ikuko Kato; Martyn Plummer; Nubia Muñoz; Federico Canzian
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 5.  Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions.

Authors:  Anca Negovan; Mihaela Iancu; Emőke Fülöp; Claudia Bănescu
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.